Trial Profile
First-line vinorelbine + carboplatin in patients with advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Apr 2014
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 29 Apr 2014 New trial record